Abstract: Time Savings with Trastuzumab Subcutaneous (SC) Injection vs. Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 5 Canadian Centres

 

Abstract: Time Savings with Trastuzumab Subcutaneous (SC) Injection vs. Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 5 Canadian Centres

Trastuzumab (TRA) subcutaneous single-use injection device (SC SID) is an alternative to intravenous (IV) administration for the treatment of HER2+ early breast cancer. This study quantifies healthcare professional (HCP) time and patient chair time related to TRA SC SID vs. TRA IV processes to estimate potential time savings with a conversion from IV to SC SID.